KR101877868B1 - 아조세미드를 유효성분으로 하는 코팅제제 - Google Patents

아조세미드를 유효성분으로 하는 코팅제제 Download PDF

Info

Publication number
KR101877868B1
KR101877868B1 KR1020137033940A KR20137033940A KR101877868B1 KR 101877868 B1 KR101877868 B1 KR 101877868B1 KR 1020137033940 A KR1020137033940 A KR 1020137033940A KR 20137033940 A KR20137033940 A KR 20137033940A KR 101877868 B1 KR101877868 B1 KR 101877868B1
Authority
KR
South Korea
Prior art keywords
titanium dioxide
mass
active ingredient
coating
content
Prior art date
Application number
KR1020137033940A
Other languages
English (en)
Korean (ko)
Other versions
KR20140047618A (ko
Inventor
가즈유키 가키미
Original Assignee
가부시키가이샤산와카가쿠켄큐쇼
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 가부시키가이샤산와카가쿠켄큐쇼 filed Critical 가부시키가이샤산와카가쿠켄큐쇼
Publication of KR20140047618A publication Critical patent/KR20140047618A/ko
Application granted granted Critical
Publication of KR101877868B1 publication Critical patent/KR101877868B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1020137033940A 2011-08-08 2012-01-11 아조세미드를 유효성분으로 하는 코팅제제 KR101877868B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2011-172968 2011-08-08
JP2011172968 2011-08-08
PCT/JP2012/050305 WO2013021660A1 (ja) 2011-08-08 2012-01-11 アゾセミドを有効成分とするコーティング製剤

Publications (2)

Publication Number Publication Date
KR20140047618A KR20140047618A (ko) 2014-04-22
KR101877868B1 true KR101877868B1 (ko) 2018-07-12

Family

ID=47668194

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020137033940A KR101877868B1 (ko) 2011-08-08 2012-01-11 아조세미드를 유효성분으로 하는 코팅제제

Country Status (5)

Country Link
JP (1) JP5270798B1 (zh)
KR (1) KR101877868B1 (zh)
CN (1) CN103096888B (zh)
HK (1) HK1179534A1 (zh)
WO (1) WO2013021660A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6339800B2 (ja) * 2013-12-27 2018-06-06 株式会社三和化学研究所 ミグリトール含有コーティング製剤
WO2016148264A1 (ja) * 2015-03-19 2016-09-22 第一三共株式会社 着色剤を含有する固形製剤
WO2016148263A1 (ja) 2015-03-19 2016-09-22 第一三共株式会社 抗酸化剤を含有する固形製剤
TWI728156B (zh) * 2016-07-27 2021-05-21 日商日本臟器製藥股份有限公司 含有胺甲蝶呤之膜衣錠
CN114159402A (zh) * 2021-12-21 2022-03-11 湖州展望天明药业有限公司 一种不透明植物胶囊及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3665002A (en) * 1968-12-20 1972-05-23 Boehringer Mannheim Gmbh 5-phenyl-tetrazole derivatives
WO1994005286A1 (de) * 1992-08-31 1994-03-17 Boehringer Mannheim Gmbh Spritzfertige azosemid-injektionslösungen
JP2004217652A (ja) * 2002-12-27 2004-08-05 Ono Pharmaceut Co Ltd コーティング製剤およびその製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4187299B2 (ja) * 1998-02-03 2008-11-26 東邦チタニウム株式会社 コーティング用二酸化チタンおよびその製造方法、二酸化チタンコーティング形成用コーティング液ならびにコーティング薬剤および食品
JP3866028B2 (ja) * 2000-10-25 2007-01-10 東邦チタニウム株式会社 コーティング用二酸化チタンおよび二酸化チタンコーティング層形成用コーティング液ならびにコーティング錠および顆粒

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3665002A (en) * 1968-12-20 1972-05-23 Boehringer Mannheim Gmbh 5-phenyl-tetrazole derivatives
WO1994005286A1 (de) * 1992-08-31 1994-03-17 Boehringer Mannheim Gmbh Spritzfertige azosemid-injektionslösungen
JP2004217652A (ja) * 2002-12-27 2004-08-05 Ono Pharmaceut Co Ltd コーティング製剤およびその製造方法

Also Published As

Publication number Publication date
JP5270798B1 (ja) 2013-08-21
CN103096888B (zh) 2014-08-27
KR20140047618A (ko) 2014-04-22
CN103096888A (zh) 2013-05-08
WO2013021660A1 (ja) 2013-02-14
JPWO2013021660A1 (ja) 2015-03-05
HK1179534A1 (zh) 2013-10-04

Similar Documents

Publication Publication Date Title
KR101877868B1 (ko) 아조세미드를 유효성분으로 하는 코팅제제
CA2568391C (en) Coated tablet formulation and method
JP7093752B2 (ja) モンテルカストナトリウム製剤
JP5365777B2 (ja) 光に対して安定なラモセトロンの固形医薬組成物
LT2011012A (lt) Stabili derinių farmacinė kompozicija
TWI708603B (zh) 含有芳基烷基胺化合物之醫藥組合物
KR101483476B1 (ko) 의약 고형 제제용의 코팅제, 의약용 필름 제제 및 피복 의약 고형 제제
KR101640958B1 (ko) 유효 성분이 경계를 사이에 두고 존재하여 이루어지는 의약 고형 제제
JP6133073B2 (ja) ループ利尿薬を有効成分とする医薬製剤
US9089558B2 (en) Packaged product of solid preparation containing 5-hydroxy-1H-imidazole-4-carboxamide or salt thereof, or hydrate thereof
JP5744340B2 (ja) フィルムコーティング用組成物
JP6367042B2 (ja) ボリコナゾールを含む医薬組成物
JP6366547B2 (ja) 光安定性が向上した、プラミペキソール製剤包装体
CN109475557A (zh) 含有甲氨蝶呤的薄膜包衣片
JP2017149748A (ja) 光安定性が向上した、プラミペキソール製剤包装体
JP2021014440A (ja) 光安定性が向上した、ダサチニブ無水物製剤の包装体
JP6339800B2 (ja) ミグリトール含有コーティング製剤
JP2018115217A (ja) 化学的安定性が改善されたエソメプラゾール塩を含有する錠剤
JP2020029447A (ja) 腸溶性高分子及び抗付着剤を含有する顆粒
WO2016016853A1 (en) Method of controlling carbamoyl impurity in pharmaceutical compositions of dabigatran
JPS61246128A (ja) 軟カプセル製剤

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right